Gov. Andrew Cuomo announced NY-Cuba Partnership for U.S. Clinical Trial of a Cuban Immunotherapy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NEW YORK Gov. Andrew Cuomo announced that a partnership formed during his New York State Trade Mission to Cuba last year has resulted in a milestone of international collaboration: the launch of a U.S. clinical trial of a Cuban immunotherapy developed by the Center of Molecular Immunology for lung cancer. Roswell Park Cancer Institute has...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The NHS-Galleri trial presented at ASCO was the largest, prospective, randomized trial of a multicancer early detection test (MCED) to date. The study enrolled approximately 143,000 asymptomatic adults (ages 50-77) and was the first of its kind to assess clinical utility of an MCED test for cancer screening. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login